Platform
Features
0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Hugh Y. Rienhoff, Jr.
15 members
9 members
5 members
4 members
3 members
Owkin
4 followers
Garuda Therapeutics
Inari
1 follower
Fortis Life Sciences
Tempus Labs
16 followers
Relay Therapeutics
Qualio
2 followers
cGMP Validation LLC
Genesis Therapeutics
Springboard Collaborative
143 followers
Illumina
67 followers
Explore companies